PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma
(MedPage Today) -- An investigational PD-1 inhibitor combined with chemotherapy showed impressive activity in treatment-naive patients with advanced extranodal natural killer/T-cell lymphoma (ENKTL), according to results from a small Chinese single... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 28, 2024 Category: Hematology Source Type: news
Kate Middleton Had to Tell Her Kids About Her Cancer Diagnosis. These Parents Know What That ’ s Like
After weeks of fevered speculation, Catherine, Princess of Wales, revealed on Mar. 22 that she was absent from the public eye not because she was having marital problems or growing out a bad haircut, but because she was being treated for cancer. She and her husband had, she said, “taken time to explain everything to George, Charlotte and Louis in a way that is appropriate for them, and to reassure them that I am going to be OK.” Even before her announcement, however, many cancer survivors who were also parents had already guessed at the truth. The silence and delay tactics looked familiar, because they had done...
Source: TIME: Health - March 28, 2024 Category: Consumer Health News Authors: Belinda Luscombe Tags: Uncategorized Cancer Source Type: news
Anti-cancer drug could improve symptoms after stroke
A study by the Institut de Neurociències of the UAB (INc-UAB) demonstrates in animal models the benefits of vorinostat after having suffered a stroke. The drug, used in humans to treat cutaneous T-cell lymphoma, has been proved to mitigate brain injuries and help in restoring brain tissue.
Ischemic stroke is the second leading cause of death worldwide and occurs when blood flow cannot reach the brain due to an obstruction. (Source: World Pharma News)
Source: World Pharma News - February 28, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Citius Pharmaceuticals Resubmits the Biologics License Application of Lymphir (denileukin diftitox) for the Treatment of Adults With Relapsed or Refractory Cutaneous T-Cell Lymphoma
CRANFORD, N.J., Feb. 13, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ( " Citius " or the " Company " ) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - February 13, 2024 Category: Drugs & Pharmacology Source Type: news
Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma
Investigators from the National Institutes of Health (NIH) report 2 partial responses (PR) in 3 peripheral T-cell lymphoma (PTCL) patients and 1 PR in 2 double-hit diffuse large b-cell lymphoma (DH-DLBCL) patients in ongoing dose-escalation trial of enitociclib in combination with venetoclax and…#nih #vincerx #paloalto #vincerxpharma #cdk9 #ahmedhamdy #nonhodgkin #ianflinn #phd #vip236 (Source: Reuters: Health)
Source: Reuters: Health - January 7, 2024 Category: Consumer Health News Source Type: news
PET/CT scans ‘crucial’ in patients with NK/T-cell lymphoma
PET/CT has significant advantages over conventional methods for lesion detection and staging in patients with natural killer/T-cell lymphoma, according to a study published December 18 in Heliyon.In a retrospective analysis, a team in Taiyuan, China, found that F-18 FDG-PET/CT was superior for analyzing imaging manifestations of NK/T-cell lymphoma and suggested that the scans can improve treatment plans for patients.“F-18 FDG-PET/CT scanning is crucial in identifying tumor lesions, determining staging, and devising treatment strategies for individuals diagnosed with NK/T-cell lymphoma,” wrote lead author Huixia Geng, M...
Source: AuntMinnie.com Headlines - December 22, 2023 Category: Radiology Authors: Will Morton Tags: Radiation Oncology/Therapy Source Type: news
CAR T Therapy May Cause Rare Cancer & How CRISPR Could Be The Solution
CAR T therapy safety falls into question as the FDA investigates reports of rare T cell lymphoma after treatment. This concern could be resolved with CRISPR technology. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 19, 2023 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news
JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma
(MedPage Today) -- Treatment with a novel, oral JAK1 tyrosine kinase inhibitor induced rapid and durable responses in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), findings from a single-arm phase II study showed.
Among... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 15, 2023 Category: Hematology Source Type: news
Dizal's Golidocitinib Pivotal Trial Demonstrates Superior and Durable Clinical Benefits for Patients with r/r PTCL in Oral Presentation at 2023 ASH
Full analysis of multinational pivotal study results of golidocitinib in relapsed or refractory peripheral T-cell lymphoma (r/r PTCL) (JACKPOT8 PART B) simultaneously published in The Lancet Oncology and presented in oral session at the 65th American Society of Hematology Annual Meeting... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 10, 2023 Category: Pharmaceuticals Tags: TRI Source Type: news
Lymphoid Reaction Observed in Eczema Patients Receiving Dupilumab
MONDAY, Oct. 30, 2023 -- For adults with atopic dermatitis (AD) receiving dupilumab treatment, a reversible lymphoid reaction (LR) has been observed, which mimics cutaneous T-cell lymphoma (CTCL), according to a study published online Oct. 18 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 30, 2023 Category: Pharmaceuticals Source Type: news
What is angioimmunoblastic T-cell lymphoma? Rare blood cancer suffered by Jurassic Park star Sam Neill, 76, affects just 5,000 Americans annually - but can kill 87% within 5 years
Sam Neill, the 76-year-old actor from New Zealand, has angioimmunoblastic T-cell lymphoma (AITL), a rare cancer affecting the lymphatic system, the body's disease-fighting network. (Source: the Mail online | Health)
Source: the Mail online | Health - October 16, 2023 Category: Consumer Health News Source Type: news
Family wonders if a quicker cancer diagnosis could have saved Thunder Bay, Ont., woman's life
A Thunder Bay, Ont., nurse who lost her mother last summer to Stage 4 T-cell lymphoma is pushing for a new policy to make it easier for patients to receive cancer diagnoses. She wants to know why a patient can't see a hematologist until the cancer is verified. Here's what we learned. (Source: CBC | Health)
Source: CBC | Health - September 25, 2023 Category: Consumer Health News Tags: News/Canada/Thunder Bay Source Type: news
Citius Pharmaceuticals, Inc. Receives Regulatory Guidance from the U.S. Food and Drug Administration (FDA) regarding the Planned Resubmission of the BLA for LYMPHIR(TM)
Resubmission to FDA planned for early 2024
CRANFORD, N.J., Sept. 8, 2023 -- (Healthcare Sales & Marketing Network) -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) is pleased to announce the Company has rec... Biopharmaceuticals, Oncology, FDA Citius Pharmaceuticals, LYMPHIR, denileukin diftitox, T-cell lymphoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 8, 2023 Category: Pharmaceuticals Source Type: news
Chlormethine Gel for the Treatment of Mycosis Fungoides Chlormethine Gel for the Treatment of Mycosis Fungoides
Review the use of chlormethine gel, a topical antineoplastic agent, for the treatment of stage IA and IB mycosis fungoides-cutaneous T-cell lymphoma.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 3, 2023 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Allo-Transplant Tied to Better PFS in Advanced Cutaneous T-Cell Lymphomas
(MedPage Today) -- Allogeneic hematopoietic stem cell transplantation (HSCT) was associated with significant improvements in progression-free survival (PFS) in patients with advanced cutaneous T-cell lymphomas (CTCLs), according to the propensity... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - May 11, 2023 Category: Dermatology Source Type: news
